The shrinking lung syndrome in systemic lupus erythematosus: Improvement with corticosteroid therapy

Lupus

Volumn 14, Issue 12, 2005, Pages 959-963

  Oud, K T M ^a,b   Bresser, P ^a   Ten Berge, R J M ^a   Jonkers, R E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Corticosteroids; Diaphragmatic weakness; Shrinking lung syndrome; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; PRIORITY JOURNAL; RARE DISEASE; SHRINKING LUNG SYNDROME; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY;

ADRENAL CORTEX HORMONES; ADULT; FEMALE; HUMANS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; SYNDROME;

EID: 30644469988     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2186cr     Document Type: Article

References (21)

1. Gibson CJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977; 63: 926-932.
2. Orens JB, Martinez FJ, Lynch JP III. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994; 20: 159-193.
3. Keane MP, Lynch JP, III. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55: 159-166.
4. Hoffbrand BI, Beck ER. 'Unexplained' dyspnoea and shrinking lungs in systemic lupus erythematosis. Br Med J 1965; 5445: 1273-1277.
5. Thompson PJ, Dhillon DP, Ledingham J, Turner-Warwick M. Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis 1985; 132: 926-928.
6. Bruschi C, Cerveri I, Zoia MC et al. Reference values of maximal respiratory mouth pressures: a population-based study. Am Rev Respir Dis 1992; 146: 790-793.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
8. Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983; 84: 170-175.
9. Stevens WM, Burdon JG, Clemens LE, Webb J. The 'shrinking lungs syndrome' - an infrequently recognised feature of systemic lupus erythematosus. Aust N Z J Med 1990; 20: 67-70.
10. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE - a clinical pathologic study. J Rheumatol 1983; 10: 973-976.
11. Laroche CM, Mulvey DA, Hawkins PN et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989; 71: 429-439.
12. Hawkins P, Davison AG, Dasgupta B, Moxham J. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001; 56: 329-330.
13. Hardy K, Herry I, Attali V, Cadranel J, Similowski T. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001; 119: 1274-1277.
14. Omdal R, Roos P, Wildhagen K, Gunnarsson R. Respiratory arrest in systemic lupus erythematosus due to phrenic nerve neuropathy. Lupus 2004; 13: 817-819.
15. Wilcox PG, Stein HB, Clarke SD, Pare PD, Pardy RL. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988; 93: 352-358.
16. Nag TC, Wadhwa S. Histopathological changes in the eyes in systemic lupus erythematosus: an electron microscope and immunohistochemical study. Histol Histopathol 2005; 20: 373-382.
17. Williams RC Jr, Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004; 50: 1239-1247.
18. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000; 75: 467-472.
19. Munoz-Rodriguez FJ, Font J, Badia JR et al. Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy. Lupus 1997; 6: 412-414.
20. Aubier M. Effect of theophylline on diaphragmatic muscle function. Chest 1987; 92 (Suppl 1): 27S-31S.
21. Van Veen S, Peeters AJ, Sterk PJ, Breedveld FC. The 'shrinking lung syndrome' in SLE, treatment with theophylline. Clin Rheumatol 1993; 12: 462-465.